232 related articles for article (PubMed ID: 23967861)
1. Inhibitors of influenza viruses replication: a patent evaluation (WO2013019828).
Xie Y; Song W; Xiao W; Gu C; Xu W
Expert Opin Ther Pat; 2013 Nov; 23(11):1517-24. PubMed ID: 23967861
[TBL] [Abstract][Full Text] [Related]
2. [The substances active against influenza virus. Possibilities and prospects of application].
Kwiatek M; Kocik J; Bartoszcze M
Przegl Epidemiol; 2009; 63(4):487-94. PubMed ID: 20120945
[TBL] [Abstract][Full Text] [Related]
3. Activity of isatine-sulfadimidine derivatives against 2009 pandemic H1N1 influenza virus in cell culture.
Selvam P; Chandramohan M; Hurst BL; Smee DF
Antivir Chem Chemother; 2010 Jan; 20(3):143-6. PubMed ID: 20054101
[TBL] [Abstract][Full Text] [Related]
4. Polyunsaturated fatty acids from Phyllocaulis boraceiensis mucus block the replication of influenza virus.
de Toledo-Piza AR; de Oliveira MI; Negri G; Mendonça RZ; Figueiredo CA
Arch Microbiol; 2018 Aug; 200(6):961-970. PubMed ID: 29616305
[TBL] [Abstract][Full Text] [Related]
5. Ching-fang-pai-tu-san inhibits the release of influenza virus.
Hsieh CF; Yen HR; Liu CH; Lin S; Horng JT
J Ethnopharmacol; 2012 Dec; 144(3):533-44. PubMed ID: 23041224
[TBL] [Abstract][Full Text] [Related]
6. Anti-influenza virus activity of biflavonoids.
Miki K; Nagai T; Suzuki K; Tsujimura R; Koyama K; Kinoshita K; Furuhata K; Yamada H; Takahashi K
Bioorg Med Chem Lett; 2007 Feb; 17(3):772-5. PubMed ID: 17110111
[TBL] [Abstract][Full Text] [Related]
7. Anti-influenza drugs and neuraminidase inhibitors.
Roberts NA
Prog Drug Res; 2001; Spec No():35-77. PubMed ID: 11548210
[TBL] [Abstract][Full Text] [Related]
8. The clinical need for new antiviral drugs directed against influenza virus.
McCullers JA
J Infect Dis; 2006 Mar; 193(6):751-3. PubMed ID: 16479505
[No Abstract] [Full Text] [Related]
9. Design, synthesis and biological evaluation of novel L-ascorbic acid-conjugated pentacyclic triterpene derivatives as potential influenza virus entry inhibitors.
Wang H; Xu R; Shi Y; Si L; Jiao P; Fan Z; Han X; Wu X; Zhou X; Yu F; Zhang Y; Zhang L; Zhang L; Zhou D; Xiao S
Eur J Med Chem; 2016 Mar; 110():376-88. PubMed ID: 26866456
[TBL] [Abstract][Full Text] [Related]
10. Use of siRNAs to prevent and treat influenza virus infection.
Ge Q; Eisen HN; Chen J
Virus Res; 2004 Jun; 102(1):37-42. PubMed ID: 15068878
[TBL] [Abstract][Full Text] [Related]
11. Identification of a novel multiple kinase inhibitor with potent antiviral activity against influenza virus by reducing viral polymerase activity.
Sasaki Y; Kakisaka M; Chutiwitoonchai N; Tajima S; Hikono H; Saito T; Aida Y
Biochem Biophys Res Commun; 2014 Jul; 450(1):49-54. PubMed ID: 24858693
[TBL] [Abstract][Full Text] [Related]
12. Enhanced expression of an alpha2,6-linked sialic acid on MDCK cells improves isolation of human influenza viruses and evaluation of their sensitivity to a neuraminidase inhibitor.
Hatakeyama S; Sakai-Tagawa Y; Kiso M; Goto H; Kawakami C; Mitamura K; Sugaya N; Suzuki Y; Kawaoka Y
J Clin Microbiol; 2005 Aug; 43(8):4139-46. PubMed ID: 16081961
[TBL] [Abstract][Full Text] [Related]
13. Anti-influenza activity of Alchemilla mollis extract: possible virucidal activity against influenza virus particles.
Makau JN; Watanabe K; Kobayashi N
Drug Discov Ther; 2013 Oct; 7(5):189-95. PubMed ID: 24270383
[TBL] [Abstract][Full Text] [Related]
14. Antiviral activity of acidic polysaccharides from Coccomyxa gloeobotrydiformi, a green alga, against an in vitro human influenza A virus infection.
Komatsu T; Kido N; Sugiyama T; Yokochi T
Immunopharmacol Immunotoxicol; 2013 Feb; 35(1):1-7. PubMed ID: 22856509
[TBL] [Abstract][Full Text] [Related]
15. Novel trivalent anti-influenza reagent.
Feng F; Miura N; Isoda N; Sakoda Y; Okamatsu M; Kida H; Nishimura S
Bioorg Med Chem Lett; 2010 Jun; 20(12):3772-6. PubMed ID: 20488701
[TBL] [Abstract][Full Text] [Related]
16. Germacrone inhibits early stages of influenza virus infection.
Liao Q; Qian Z; Liu R; An L; Chen X
Antiviral Res; 2013 Dec; 100(3):578-88. PubMed ID: 24095670
[TBL] [Abstract][Full Text] [Related]
17. Influenza chemotherapy: a review of the present state of art and of new drugs in development.
Lüscher-Mattli M
Arch Virol; 2000; 145(11):2233-48. PubMed ID: 11205114
[TBL] [Abstract][Full Text] [Related]
18. Anti-influenza Activity of a Bacillus subtilis Probiotic Strain.
Starosila D; Rybalko S; Varbanetz L; Ivanskaya N; Sorokulova I
Antimicrob Agents Chemother; 2017 Jul; 61(7):. PubMed ID: 28416546
[TBL] [Abstract][Full Text] [Related]
19. Achieving clinical equality in an influenza pandemic: patent realities.
Kane EM
Seton Hall Law Rev; 2009; 39(4):1137-72. PubMed ID: 20718133
[TBL] [Abstract][Full Text] [Related]
20. Microwave assisted synthesis and anti-influenza virus activity of 1-adamantyl substituted N-(1-thia-4-azaspiro[4.5]decan-4-yl)carboxamide derivatives.
Göktaş F; Vanderlinden E; Naesens L; Cesur N; Cesur Z
Bioorg Med Chem; 2012 Dec; 20(24):7155-9. PubMed ID: 23117173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
